GlobalData on MSN

The new safety mandate driving AI-ready pharmacovigilance

Deepanshu Saini, Director of Program Management at IQVIA reflects on the interplay between safety and AI pharmacovigilance.
EconoTimes

FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns

The U.S. Food and Drug Administration has delayed reviews of several drugs selected for the Trump administrations new ...

Exclusive-US FDA delays two drug reviews in new voucher program after safety, efficacy concerns

By Patrick Wingrove Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the ...

New research identifies key strategies for global drug safety studies

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
MM&M

FDA layoffs could compromise safety of medications made at foreign factories, inspectors say

This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

US, European regulators set principles for 'good AI practice' in drug development

Jan 14 (Reuters) - The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe ...
RealClearMarketsOpinion

Let's Not Allow Politics To Break the Generic Drug Market

Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 ...
Forbes

We Import Too Many Substandard Generic Drugs: Five Steps To Safety

Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...